{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T08:33:29Z","timestamp":1793262809662,"version":"4.5.0"},"reference-count":282,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001409","name":"Department of Science and Technology, Ministry of Science and Technology, India","doi-asserted-by":"publisher","award":["SR\/PURSE\/2024\/350 dated 14-10-2024"],"award-info":[{"award-number":["SR\/PURSE\/2024\/350 dated 14-10-2024"]}],"id":[{"id":"10.13039\/501100001409","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010438","name":"Uniwersytet Medyczny im. Karola Marcinkowskiego w Poznaniu","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100010438","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009053","name":"Wellcome Trust DBT India Alliance","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100009053","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Advances in Colloid and Interface Science"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.cis.2026.103965","type":"journal-article","created":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T16:10:07Z","timestamp":1780675807000},"page":"103965","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Nanoscale interrogation of \u03b1-Synuclein oligomers: Bridging biophysics, interface science, and neurobiology"],"prefix":"10.1016","volume":"356","author":[{"given":"Magdalena","family":"Goncerz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B\u0142a\u017cej","family":"Rubi\u015b","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marta","family":"Szukalska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ewa","family":"Toto\u0144","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monika","family":"Nehra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ida","family":"Malesza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrycja","family":"Sujka-Kordowska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara","family":"Jachimska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ewa","family":"Florek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edyta","family":"M\u0105dry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandeep","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ma\u0142gorzata","family":"Kujawska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cis.2026.103965_bb0005","first-page":"31","article-title":"Synaptic failure and \u03b1-synuclein","author":"Calo","year":"2016","journal-title":"Mov Disord"},{"key":"10.1016\/j.cis.2026.103965_bb0010","first-page":"39","article-title":"Synaptic vesicle binding of \u03b1-synuclein is modulated by \u03b2- and \u03b3-synucleins","author":"Carnazza","year":"2022","journal-title":"Cell Rep"},{"key":"10.1016\/j.cis.2026.103965_bb0015","first-page":"88","article-title":"Dynamic structural flexibility of \u03b1-synuclein","author":"Mor","year":"2016","journal-title":"Neurobiol Dis"},{"key":"10.1016\/j.cis.2026.103965_bb0020","first-page":"435","article-title":"\u03b1-Synuclein conformational strains as drivers of phenotypic heterogeneity in neurodegenerative diseases","author":"So","year":"2023","journal-title":"J Mol Biol"},{"key":"10.1016\/j.cis.2026.103965_bb0025","first-page":"18","article-title":"\u03b1-Synuclein oligomers and fibrils: partners in crime in synucleinopathies","author":"Bigi","year":"2023","journal-title":"Neural Regen Res"},{"key":"10.1016\/j.cis.2026.103965_bb0030","first-page":"9","article-title":"Early stages of aggregation of engineered \u03b1-synuclein monomers and oligomers in solution","author":"Li","year":"2019","journal-title":"Sci Rep"},{"key":"10.1016\/j.cis.2026.103965_bb0035","first-page":"17","article-title":"Single-molecule detection of \u03b1-synuclein oligomers in parkinson\u2019s disease patients using nanopores","author":"Liu","year":"2023","journal-title":"ACS Nano"},{"key":"10.1016\/j.cis.2026.103965_bb0040","first-page":"21","article-title":"WT and a53t \u03b1-synuclein systems: Melting diagram and its new interpretation","author":"Bokor","year":"2020","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.cis.2026.103965_bb0045","first-page":"22","article-title":"Membrane affinity of individual toxic protein oligomers determined at the single-molecule level","author":"Dey","year":"2020","journal-title":"Phys Chem Chem Phys"},{"key":"10.1016\/j.cis.2026.103965_bb0050","first-page":"54","article-title":"Membrane interactions of \u03b1-synuclein probed by neutrons and photons","author":"Kaur","year":"2021","journal-title":"Acc Chem Res"},{"key":"10.1016\/j.cis.2026.103965_bb0055","first-page":"9","article-title":"\u03b1-synuclein oligomers interact with ATP synthase and open the permeability transition pore in Parkinson\u2019s disease","author":"Ludtmann","year":"2018","journal-title":"Nat Commun"},{"key":"10.1016\/j.cis.2026.103965_bb0060","first-page":"18","article-title":"\u03b1-Synuclein oligomers displace monomeric \u03b1-synuclein from lipid membranes","author":"\u0160neiderien\u0117","year":"2024","journal-title":"ACS Nano"},{"key":"10.1016\/j.cis.2026.103965_bb0065","article-title":"Computational studies of protein aggregation mediated by amyloid: Fibril elongation and secondary nucleation","volume":"170","author":"Cao","year":"2020","journal-title":"Prog Mol Biol Transl Sci"},{"key":"10.1016\/j.cis.2026.103965_bb0070","doi-asserted-by":"crossref","DOI":"10.1016\/j.bpc.2023.107143","article-title":"The density of anionic lipids modulates the adsorption of \u03b1-synuclein onto lipid membranes","volume":"305","author":"Andersson","year":"2024","journal-title":"Biophys Chem"},{"key":"10.1016\/j.cis.2026.103965_bb0075","first-page":"14","article-title":"Interaction of alpha-synuclein and its mutants with rigid lipid vesicle mimics of varying surface curvature","author":"McClain","year":"2020","journal-title":"ACS Nano"},{"key":"10.1016\/j.cis.2026.103965_bb0080","first-page":"132","article-title":"Extracellular \u03b1-synuclein alters synaptic transmission in brain neurons by perforating the neuronal plasma membrane","author":"Pacheco","year":"2015","journal-title":"J Neurochem"},{"key":"10.1016\/j.cis.2026.103965_bb0085","doi-asserted-by":"crossref","first-page":"1867","DOI":"10.1002\/cjoc.202400155","article-title":"Revealing the regulation effect of surface charge at aromatic interface to dynamic conformational changes of \u03b1-synuclein at early aggregation stage","volume":"42","author":"Zhang","year":"2024","journal-title":"Chin J Chem"},{"key":"10.1016\/j.cis.2026.103965_bb0090","first-page":"5","article-title":"Endogenous alpha-synuclein monomers, oligomers and resulting pathology: let\u2019s talk about the lipids in the room","author":"Killinger","year":"2019","journal-title":"NPJ Parkinsons Dis"},{"key":"10.1016\/j.cis.2026.103965_bb0095","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.jmb.2005.10.071","article-title":"Secondary structure of \u03b1-synuclein oligomers: characterization by raman and atomic force microscopy","volume":"355","author":"Apetri","year":"2006","journal-title":"J Mol Biol"},{"key":"10.1016\/j.cis.2026.103965_bb0100","first-page":"1871","article-title":"Kinetic control in amyloid polymorphism: Different agitation and solution conditions promote distinct amyloid polymorphs of alpha-synuclein","author":"Devi","year":"2023","journal-title":"Biochim Biophys Acta, Proteins Proteomics"},{"key":"10.1016\/j.cis.2026.103965_bb0105","first-page":"18","article-title":"Characterization of the non-fibrillar -synuclein oligomers","author":"Hong","year":"2011","journal-title":"Protein Pept Lett"},{"key":"10.1016\/j.cis.2026.103965_bb0110","first-page":"7","article-title":"Evidence for intramolecular antiparallel beta-sheet structure in alpha-synuclein fibrils from a combination of two-dimensional infrared spectroscopy and atomic force microscopy","author":"Roeters","year":"2017","journal-title":"Sci Rep"},{"key":"10.1016\/j.cis.2026.103965_bb0115","first-page":"87","article-title":"Fast flow microfluidics and single-molecule fluorescence for the rapid characterization of \u03b1-synuclein oligomers","author":"Horrocks","year":"2015","journal-title":"Anal Chem"},{"key":"10.1016\/j.cis.2026.103965_bb0120","first-page":"146","author":"Kumar","year":"2020","journal-title":"Neurobiol Dis"},{"key":"10.1016\/j.cis.2026.103965_bb0125","first-page":"145","article-title":"Multiplexed digital characterization of misfolded protein oligomers via solid-state nanopores","author":"Sandler","year":"2023","journal-title":"J Am Chem Soc"},{"key":"10.1016\/j.cis.2026.103965_bb0130","first-page":"104","article-title":"In vitro study of \u03b1-synuclein protofibrils by Cryo-EM suggests a Cu2+-dependent aggregation pathway","author":"Zhang","year":"2013","journal-title":"Biophys J"},{"key":"10.1016\/j.cis.2026.103965_bb0135","first-page":"12","article-title":"Effects of \u03b1-synuclein-associated post-translational modifications in parkinson\u2019s disease","author":"He","year":"2021","journal-title":"ACS Chem Neurosci"},{"key":"10.1016\/j.cis.2026.103965_bb0140","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0252635","article-title":"Polo-like kinase 2 inhibition reduces serine-129 phosphorylation of physiological nuclear alpha-synuclein but not of the aggregated alpha-synuclein","volume":"16","author":"Elfarrash","year":"2021","journal-title":"PLoS One"},{"key":"10.1016\/j.cis.2026.103965_bb0145","first-page":"9","article-title":"Modelling Ser129 phosphorylation inhibits membrane binding of pore-forming alpha-synuclein oligomers","author":"N\u00fcbling","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.cis.2026.103965_bb0150","doi-asserted-by":"crossref","DOI":"10.1016\/j.neurobiolaging.2015.06.004","article-title":"Increased oligomerization and phosphorylation of \u03b1-synuclein are associated with decreased activity of glucocerebrosidase and protein phosphatase 2A in aging monkey brains","volume":"36","author":"Liu","year":"2015","journal-title":"Neurobiol Aging"},{"key":"10.1016\/j.cis.2026.103965_bb0155","first-page":"119","article-title":"\u03b1-Synuclein phosphorylation at serine 129 occurs after initial protein deposition and inhibits seeded fibril formation and toxicity","author":"Ghanem","year":"2022","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.cis.2026.103965_bb0160","first-page":"14","article-title":"Implications of in vitro multi-serine phosphorylation of alpha-synuclein in aggregation and cytotoxicity","author":"Chaturvedi","year":"2023","journal-title":"ACS Chem Neurosci"},{"key":"10.1016\/j.cis.2026.103965_bb0165","first-page":"1874","article-title":"Nitrated products formed on \u03b1-synuclein are preferentially incorporated into oligomers but excluded from fibrils: A mechanism for accumulation of neurotoxic species","author":"Otzen","year":"2026","journal-title":"Biochim Biophys Acta, Proteins Proteomics"},{"key":"10.1016\/j.cis.2026.103965_bb0170","first-page":"90","article-title":"Truncation or proteolysis of \u03b1-synuclein in Parkinsonism","author":"Suthar","year":"2023","journal-title":"Ageing Res Rev"},{"key":"10.1016\/j.cis.2026.103965_bb0175","first-page":"61","article-title":"N-Terminal acetylation of \u03b1-synuclein slows down its aggregation process and alters the morphology of the resulting aggregates","author":"Bell","year":"2022","journal-title":"Biochemistry"},{"key":"10.1016\/j.cis.2026.103965_bb0180","doi-asserted-by":"crossref","DOI":"10.1088\/1478-3975\/abb6dc","article-title":"O-GlcNAcylation inhibits the oligomerization of alpha-synuclein by declining intermolecular hydrogen bonds through a steric effect","volume":"18","author":"Wu","year":"2020","journal-title":"Phys Biol"},{"key":"10.1016\/j.cis.2026.103965_bb0185","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1021\/acschembio.0c00716","article-title":"Comparison of N-acetyl-glucosamine to other monosaccharides reveals structural differences for the inhibition of \u03b1-synuclein aggregation","volume":"16","author":"Galesic","year":"2021","journal-title":"ACS Chem Biol"},{"issue":"1","key":"10.1016\/j.cis.2026.103965_bb0190","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1038\/s41531-025-01084-y","article-title":"Differential role of C-terminal truncations on alpha-synuclein pathology and Lewy body formation","volume":"11","author":"Mahul-Mellier","year":"2025","journal-title":"Npj Parkinson\u2019s Dis"},{"key":"10.1016\/j.cis.2026.103965_bb0195","first-page":"10","article-title":"\u03b1-synuclein seed amplification assays in the diagnosis of synucleinopathies using cerebrospinal fluid\u2014A systematic review and meta-analysis","author":"Grossauer","year":"2023","journal-title":"Mov Disord Clin Pract"},{"key":"10.1016\/j.cis.2026.103965_bb0200","first-page":"73","article-title":"\u03b1-synuclein oligomers and clinical implications for parkinson disease","author":"Kalia","year":"2013","journal-title":"Ann Neurol"},{"key":"10.1016\/j.cis.2026.103965_bb0205","article-title":"A 2D fragment-assisted protein mimetic approach to rescue \u03b1synuclein aggregation mediated early and post-disease parkinson\u2019s phenotypes","author":"Stillman","year":"2022","journal-title":"BioRxiv"},{"key":"10.1016\/j.cis.2026.103965_bb0210","first-page":"12","article-title":"The Hsc70 disaggregation machinery removes monomer units directly from \u03b1-synuclein fibril ends","author":"Schneider","year":"2021","journal-title":"Nat Commun"},{"key":"10.1016\/j.cis.2026.103965_bb0215","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines10092168","article-title":"Rational generation of monoclonal antibodies selective for pathogenic forms of alpha-synuclein","volume":"10","author":"Gibbs","year":"2022","journal-title":"Biomedicines"},{"key":"10.1016\/j.cis.2026.103965_bb0220","first-page":"106","article-title":"Repositioning doxycycline for treating synucleinopathies: Evidence from a pre-clinical mouse model","author":"La Vitola","year":"2023","journal-title":"Parkinsonism Relat Disord"},{"key":"10.1016\/j.cis.2026.103965_bb0225","doi-asserted-by":"crossref","first-page":"2201","DOI":"10.1039\/D5BM00179J","article-title":"Biofunctionalized nanomaterials for Parkinson\u2019s disease theranostics: Potential for efficient PD biomarker detection and effective therapy","volume":"13","author":"Sabnam","year":"2025","journal-title":"Biomater Sci"},{"key":"10.1016\/j.cis.2026.103965_bb0230","first-page":"92","article-title":"Structural characterization of individual \u03b1-synuclein oligomers formed at different stages of protein aggregation by atomic force microscopy-infrared spectroscopy","author":"Zhou","year":"2020","journal-title":"Anal Chem"},{"key":"10.1016\/j.cis.2026.103965_bb0235","first-page":"5","article-title":"Single-molecule FRET studies on alpha-synuclein oligomerization of Parkinson\u2019s disease genetically related mutants","author":"Tosatto","year":"2015","journal-title":"Sci Rep"},{"key":"10.1016\/j.cis.2026.103965_bb0240","doi-asserted-by":"crossref","DOI":"10.1016\/j.cis.2021.102561","article-title":"Solid-state and polymer nanopores for protein sensing: A review","volume":"298","author":"Meyer","year":"2021","journal-title":"Adv Colloid Interf Sci"},{"key":"10.1016\/j.cis.2026.103965_bb0245","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2019.10.089","article-title":"In vivo protein complementation demonstrates presynaptic \u03b1-synuclein oligomerization and age-dependent accumulation of 8\u201316-mer oligomer species","volume":"29","author":"Kiechle","year":"2019","journal-title":"Cell Rep"},{"key":"10.1016\/j.cis.2026.103965_bb0250","first-page":"4","article-title":"Optogenetic-mediated induction and monitoring of \u03b1-synuclein aggregation in cellular models of Parkinson\u2019s disease","author":"Teixeira","year":"2023","journal-title":"STAR Protoc"},{"key":"10.1016\/j.cis.2026.103965_bb0255","first-page":"5","article-title":"The synaptic function of \u03b1-synuclein","author":"Burr\u00e9","year":"2015","journal-title":"J Parkinsons Dis"},{"key":"10.1016\/j.cis.2026.103965_bb0260","first-page":"50","article-title":"A glimpse into the structural properties of \u03b1-synuclein oligomers","author":"Santos","year":"2024","journal-title":"BioFactors"},{"key":"10.1016\/j.cis.2026.103965_bb0265","first-page":"61","article-title":"New insights on the structure of alpha-synuclein fibrils using cryo-electron microscopy","author":"Guerrero-Ferreira","year":"2020","journal-title":"Curr Opin Neurobiol"},{"key":"10.1016\/j.cis.2026.103965_bb0270","first-page":"15","article-title":"\u03b1-Synuclein oligomers form by secondary nucleation","author":"Xu","year":"2024","journal-title":"Nat Commun"},{"key":"10.1016\/j.cis.2026.103965_bb0275","first-page":"14","article-title":"Interaction of alpha-synuclein with lipids: mitochondrial cardiolipin as a critical player in the pathogenesis of parkinson\u2019s disease","author":"Gilmozzi","year":"2020","journal-title":"Front Neurosci"},{"key":"10.1016\/j.cis.2026.103965_bb0280","first-page":"8","article-title":"A NAC domain mutation (E83Q) unlocks the pathogenicity of human alpha-synuclein and recapitulates its pathological diversity","author":"Kumar","year":"2022","journal-title":"Sci Adv"},{"key":"10.1016\/j.cis.2026.103965_bb0285","first-page":"4","article-title":"Structures and free energy landscapes of the A53T mutant-type \u03b1-synuclein protein and impact of A53T mutation on the structures of the wild-type \u03b1-synuclein protein with dynamics","author":"Coskuner","year":"2013","journal-title":"ACS Chem Neurosci"},{"key":"10.1016\/j.cis.2026.103965_bb0290","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/bs.pmbts.2024.11.004","article-title":"Factors responsible for alpha-synuclein aggregation","volume":"211","author":"Singh","year":"2025","journal-title":"Prog Mol Biol Transl Sci"},{"key":"10.1016\/j.cis.2026.103965_bb0295","first-page":"14","article-title":"Alpha-synuclein in Parkinson\u2019s disease and other synucleinopathies: from overt neurodegeneration back to early synaptic dysfunction","author":"Calabresi","year":"2023","journal-title":"Cell Death Dis"},{"key":"10.1016\/j.cis.2026.103965_bb0300","first-page":"15","article-title":"Navigating the dynamic landscape of alpha-synuclein morphology: A review of the physiologically relevant tetrameric conformation","author":"Lucas","year":"2020","journal-title":"Neural Regen Res"},{"key":"10.1016\/j.cis.2026.103965_bb0305","first-page":"25","article-title":"Alpha-synuclein contribution to neuronal and glial damage in Parkinson\u2019s disease","author":"Saramowicz","year":"2024","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.cis.2026.103965_bb0310","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbamem.2020.183536","article-title":"Interactions of \u03b1-synuclein oligomers with lipid membranes","volume":"1863","author":"Musteikyt\u0117","year":"2021","journal-title":"Biochim Biophys Acta Biomembr"},{"key":"10.1016\/j.cis.2026.103965_bb0315","doi-asserted-by":"crossref","DOI":"10.1016\/j.arr.2024.102538","article-title":"Small molecule modulators of alpha-synuclein aggregation and toxicity: Pioneering an emerging arsenal against Parkinson\u2019s disease","volume":"101","author":"Ahanger","year":"2024","journal-title":"Ageing Res Rev"},{"key":"10.1016\/j.cis.2026.103965_bb0320","first-page":"134","article-title":"Alpha-synuclein oligomers: A new hope","author":"Bengoa-Vergniory","year":"2017","journal-title":"Acta Neuropathol"},{"key":"10.1016\/j.cis.2026.103965_bb0325","first-page":"79","article-title":"Effects of oligomer toxicity, fibril toxicity and fibril spreading in synucleinopathies","author":"Cascella","year":"2022","journal-title":"Cell Mol Life Sci"},{"key":"10.1016\/j.cis.2026.103965_bb0330","first-page":"443","article-title":"Toxic prefibrillar \u03b1-synuclein amyloid oligomers adopt a distinctive antiparallel \u03b2-sheet structure","author":"Celej","year":"2012","journal-title":"Biochem J"},{"key":"10.1016\/j.cis.2026.103965_bb0335","doi-asserted-by":"crossref","DOI":"10.1021\/acschembio.5c00686","article-title":"Multiomic analysis reveals molecular pathways associated with intestinal aggregation of \u03b1-synuclein","author":"Balsamo","year":"2026","journal-title":"ACS Chem Biol"},{"key":"10.1016\/j.cis.2026.103965_bb0340","first-page":"49","article-title":"Stabilization and reduced cytotoxicity of amyloid beta aggregates in the presence of catechol neurotransmitters","author":"Allnutt","year":"2024","journal-title":"Neurochem Res"},{"key":"10.1016\/j.cis.2026.103965_bb0345","first-page":"21","article-title":"The role of \u03b1-synuclein oligomers in parkinson\u2019s disease","author":"Du","year":"2020","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.cis.2026.103965_bb0350","first-page":"10","article-title":"Amyloid oligomers as on-pathway precursors or off-pathway competitors of fibrils","author":"Muschol","year":"2023","journal-title":"Front Mol Biosci"},{"key":"10.1016\/j.cis.2026.103965_bb0355","doi-asserted-by":"crossref","DOI":"10.1016\/j.jmb.2025.169048","article-title":"Off-pathway oligomers of \u03b1-synuclein and A\u03b2 inhibit secondary nucleation of \u03b1-synuclein amyloid fibrils","volume":"437","author":"Sch\u00fctzmann","year":"2025","journal-title":"J Mol Biol"},{"key":"10.1016\/j.cis.2026.103965_bb0360","first-page":"116","article-title":"\u03b1-synuclein dimer structures found from computational simulations","author":"Sahu","year":"2015","journal-title":"Biochimie"},{"key":"10.1016\/j.cis.2026.103965_bb0365","first-page":"148","article-title":"High-speed atomic force microscopy reveals structural dynamics of \u03b1 -synuclein monomers and dimers","author":"Zhang","year":"2018","journal-title":"J Chem Phys"},{"key":"10.1016\/j.cis.2026.103965_bb0370","first-page":"27","article-title":"Implementing complementary approaches to shape the mechanism of \u03b1-synuclein oligomerization as a model of amyloid aggregation","author":"Giamp\u00e0","year":"2022","journal-title":"Molecules"},{"key":"10.1016\/j.cis.2026.103965_bb0375","first-page":"120","article-title":"Spontaneous nucleation and fast aggregate-dependent proliferation of \u03b1-synuclein aggregates within liquid condensates at neutral pH","author":"Dada","year":"2023","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.cis.2026.103965_bb0380","doi-asserted-by":"crossref","first-page":"7229","DOI":"10.1039\/D3SC05661A","article-title":"Molecular mechanism of \u03b1-synuclein aggregation on lipid membranes revealed","volume":"15","author":"Dear","year":"2024","journal-title":"Chem Sci"},{"key":"10.1016\/j.cis.2026.103965_bb0385","article-title":"Structural characteristics of \u03b1-synuclein oligomers","volume":"329","author":"Cremades","year":"2017","journal-title":"Int Rev Cell Mol Biol"},{"key":"10.1016\/j.cis.2026.103965_bb0390","first-page":"149","article-title":"Direct observation of the interconversion of normal and toxic forms of \u03b1-synuclein","author":"Cremades","year":"2012","journal-title":"Cell"},{"key":"10.1016\/j.cis.2026.103965_bb0395","first-page":"686","article-title":"Methods for measuring aptamer-protein equilibria: A review","author":"Jing","year":"2011","journal-title":"Anal Chim Acta"},{"key":"10.1016\/j.cis.2026.103965_bb0400","first-page":"98","article-title":"Early aggregation steps in \u03b1-synuclein as measured by FCS and FRET: Evidence for a contagious conformational change","author":"Nath","year":"2010","journal-title":"Biophys J"},{"key":"10.1016\/j.cis.2026.103965_bb0405","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1007\/s12104-024-10188-0","article-title":"Solid-state NMR assignment of \u03b1-synuclein polymorph prepared from helical intermediate","volume":"18","author":"Ahlawat","year":"2024","journal-title":"Biomol NMR Assign"},{"key":"10.1016\/j.cis.2026.103965_bb0410","first-page":"5","article-title":"Structure based aggregation studies reveal the presence of helix-rich intermediate during \u03b1-Synuclein aggregation","author":"Ghosh","year":"2015","journal-title":"Sci Rep"},{"key":"10.1016\/j.cis.2026.103965_bb0415","first-page":"112","article-title":"Structural characterization of toxic oligomers that are kinetically trapped during \u03b1-synuclein fibril formation","author":"Chen","year":"2015","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.cis.2026.103965_bb0420","first-page":"358","article-title":"Structural basis of membrane disruption and cellular toxicity by a-synuclein oligomers","volume":"2017","author":"Fusco","year":"1979","journal-title":"Science"},{"key":"10.1016\/j.cis.2026.103965_bb0425","first-page":"8","article-title":"Structural characteristics and membrane interactions of tandem \u03b1-synuclein oligomers","author":"Dong","year":"2018","journal-title":"Sci Rep"},{"key":"10.1016\/j.cis.2026.103965_bb0430","first-page":"38","article-title":"Characterization of \u03b1-synuclein oligomers formed in the presence of lipid vesicles","author":"Dasari","year":"2024","journal-title":"Biochem Biophys Rep"},{"key":"10.1016\/j.cis.2026.103965_bb0435","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-025-55849-3","article-title":"Lipidic folding pathway of \u03b1-Synuclein via a toxic oligomer","volume":"16","author":"Sant","year":"2025","journal-title":"Nat Commun"},{"key":"10.1016\/j.cis.2026.103965_bb0440","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/j.str.2023.01.005","article-title":"Solid-state NMR studies of amyloids","volume":"31","author":"Liu","year":"2023","journal-title":"Structure"},{"issue":"2019","key":"10.1016\/j.cis.2026.103965_bb0445","first-page":"20","article-title":"In-cell NMR: analysis of protein\u2013small molecule interactions, metabolic processes, and protein phosphorylation","volume":"20","author":"Kumar","year":"2019","journal-title":"Int J Mol Sci"},{"issue":"2019","key":"10.1016\/j.cis.2026.103965_bb0450","first-page":"20","article-title":"Applications of in-cell NMR in structural biology and drug discovery","volume":"20","author":"Kang","year":"2019","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.cis.2026.103965_bb0455","first-page":"176","article-title":"Monitoring \u03b1-synuclein aggregation","author":"Estaun-Panzano","year":"2023","journal-title":"Neurobiol Dis"},{"key":"10.1016\/j.cis.2026.103965_bb0460","doi-asserted-by":"crossref","DOI":"10.1098\/rsos.191204","article-title":"Liquid cell transmission electron microscopy and its applications","volume":"7","author":"Pu","year":"2020","journal-title":"R Soc Open Sci"},{"key":"10.1016\/j.cis.2026.103965_bb0465","first-page":"15","article-title":"High-resolution cryo-EM structure determination of a-synuclein\u2014A prototypical amyloid fibril","author":"Sanchez","year":"2025","journal-title":"Bio Protoc"},{"key":"10.1016\/j.cis.2026.103965_bb0470","first-page":"610","article-title":"Structures of \u03b1-synuclein filaments from human brains with Lewy pathology","author":"Yang","year":"2022","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.cis.2026.103965_bb0475","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1038\/s42003-021-02026-z","article-title":"Conformational distortion in a fibril-forming oligomer arrests alpha-synuclein fibrillation and minimizes its toxic effects","volume":"4","author":"Chakraborty","year":"2021","journal-title":"Commun Biol"},{"key":"10.1016\/j.cis.2026.103965_bb0480","first-page":"26","article-title":"Single molecule characterization of amyloid oligomers","author":"Yang","year":"2021","journal-title":"Molecules"},{"key":"10.1016\/j.cis.2026.103965_bb0485","doi-asserted-by":"crossref","first-page":"2937","DOI":"10.1039\/D2AY00611A","article-title":"A FRET-based aptasensor for the detection of \u03b1-synuclein oligomers as biomarkers of Parkinson\u2019s disease","volume":"14","author":"Saedi","year":"2022","journal-title":"Anal Methods"},{"key":"10.1016\/j.cis.2026.103965_bb0490","first-page":"9","article-title":"Diverse metastable structures formed by small oligomers of \u03b1-synuclein probed by force spectroscopy","author":"Neupane","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.cis.2026.103965_bb0495","first-page":"117","article-title":"Probing the basis of \u03b1-synuclein aggregation by comparing simulations to single-molecule experiments","author":"Churchill","year":"2019","journal-title":"Biophys J"},{"key":"10.1016\/j.cis.2026.103965_bb0500","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1038\/s41570-025-00694-7","article-title":"Detection of protein oligomers with nanopores","volume":"9","author":"Horne","year":"2025","journal-title":"Nat Rev Chem"},{"key":"10.1016\/j.cis.2026.103965_bb0505","first-page":"6","article-title":"Intrinsic and membrane-facilitated \u03b1-synuclein oligomerization revealed by label-free detection through solid-state nanopores","author":"Hu","year":"2016","journal-title":"Sci Rep"},{"key":"10.1016\/j.cis.2026.103965_bb0510","first-page":"17","article-title":"Simultaneous determination of the size and shape of single \u03b1-synuclein oligomers in solution","author":"Awasthi","year":"2023","journal-title":"ACS Nano"},{"key":"10.1016\/j.cis.2026.103965_bb0515","first-page":"8","article-title":"Characterizing prion-like protein aggregation: Emerging nanopore-based approaches","author":"Meyer","year":"2024","journal-title":"Small Methods"},{"key":"10.1016\/j.cis.2026.103965_bb0520","first-page":"338","article-title":"In vitro biosensing of \u03b2-Amyloid peptide aggregation dynamics using a biological nanopore","author":"Lenhart","year":"2021","journal-title":"Sensors Actuators B Chem"},{"key":"10.1016\/j.cis.2026.103965_bb0525","first-page":"43","article-title":"Using mass spectrometry-based methods to understand amyloid formation and inhibition of alpha-synuclein and amyloid beta","author":"Wagner","year":"2024","journal-title":"Mass Spectrom Rev"},{"key":"10.1016\/j.cis.2026.103965_bb0530","first-page":"29","article-title":"Native top-down mass spectrometry and ion mobility ms for characterizing the cobalt and manganese metal binding of \u03b1-synuclein protein","author":"Wongkongkathep","year":"2018","journal-title":"J Am Soc Mass Spectrom"},{"key":"10.1016\/j.cis.2026.103965_bb0535","first-page":"34","article-title":"Characterization of molecular tweezer binding on \u03b1-synuclein with native top-down mass spectrometry and ion mobility-mass spectrometry reveals a mechanism for aggregation inhibition","author":"Lantz","year":"2023","journal-title":"J Am Soc Mass Spectrom"},{"key":"10.1016\/j.cis.2026.103965_bb0540","first-page":"2","article-title":"Optical biosensors for diagnosing neurodegenerative diseases","author":"Duy Mac","year":"2025","journal-title":"Npj Biosens"},{"key":"10.1016\/j.cis.2026.103965_bb0545","first-page":"117","article-title":"Single-vesicle imaging reveals lipid-selective and stepwise membrane disruption by monomeric a-synuclein","author":"Hannestad","year":"2020","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.cis.2026.103965_bb0550","first-page":"12","article-title":"Optical tweezers-controlled hotspot for sensitive and reproducible surface-enhanced Raman spectroscopy characterization of native protein structures","author":"Dai","year":"2021","journal-title":"Nat Commun"},{"key":"10.1016\/j.cis.2026.103965_bb0555","first-page":"13","article-title":"Phosphatidylcholine and phosphatidylserine uniquely modify the secondary structure of \u03b1-synuclein oligomers formed in their presence at the early stages of protein aggregation","author":"Dou","year":"2022","journal-title":"ACS Chem Neurosci"},{"key":"10.1016\/j.cis.2026.103965_bb0560","first-page":"245","article-title":"Aptasensors for the selective detection of alpha-synuclein oligomer by colorimetry, surface plasmon resonance and electrochemical impedance spectroscopy","author":"Sun","year":"2017","journal-title":"Sensors Actuators B Chem"},{"key":"10.1016\/j.cis.2026.103965_bb0565","first-page":"14","article-title":"Drug repurposing screens identify compounds that inhibit \u03b1-synuclein oligomers\u2019 membrane disruption and block antibody interactions","author":"Somavarapu","year":"2023","journal-title":"Chem Sci"},{"key":"10.1016\/j.cis.2026.103965_bb0570","first-page":"142","article-title":"Cellular prion protein neither binds to alpha-synuclein oligomers nor mediates their detrimental effects","author":"La Vitola","year":"2019","journal-title":"Brain"},{"issue":"2025","key":"10.1016\/j.cis.2026.103965_bb0575","first-page":"26","article-title":"Role of the surface in conformational changes in lysozymes: effect of a gold surface and a lipid membrane","volume":"26","author":"Kaminska","year":"2025","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.cis.2026.103965_bb0580","first-page":"166","article-title":"Adsorption and decontamination of \u03b1-synuclein from medically and environmentally-relevant surfaces","author":"Phan","year":"2018","journal-title":"Colloids Surf B: Biointerfaces"},{"key":"10.1016\/j.cis.2026.103965_bb0585","first-page":"415","article-title":"Tunable lipid-coated nanoporous silver sheet for characterization of protein-membrane interactions by surface-enhanced Raman scattering (SERS)","author":"Zhu","year":"2023","journal-title":"Anal Bioanal Chem"},{"key":"10.1016\/j.cis.2026.103965_bb0590","first-page":"12","article-title":"Unravelling the structural organization of individual \u03b1-synuclein oligomers grown in the presence of phospholipids","author":"Dou","year":"2021","journal-title":"J Phys Chem Lett"},{"key":"10.1016\/j.cis.2026.103965_bb0595","first-page":"14","article-title":"Elucidation of secondary structure and toxicity of \u03b1-synuclein oligomers and fibrils grown in the presence of phosphatidylcholine and phosphatidylserine","author":"Dou","year":"2023","journal-title":"ACS Chem Neurosci"},{"key":"10.1016\/j.cis.2026.103965_bb0600","first-page":"37","article-title":"The formation of highly soluble oligomers of \u03b1-synuclein is regulated by fatty acids and enhanced in Parkinson\u2019s disease","author":"Sharon","year":"2003","journal-title":"Neuron"},{"key":"10.1016\/j.cis.2026.103965_bb0605","first-page":"1834","article-title":"Advances in ion mobility spectrometry-mass spectrometry reveal key insights into amyloid assembly","author":"Woods","year":"2013","journal-title":"Biochim Biophys Acta, Proteins Proteomics"},{"key":"10.1016\/j.cis.2026.103965_bb0610","doi-asserted-by":"crossref","first-page":"2570","DOI":"10.1039\/c3nr33193h","article-title":"Protein fibrillation and nanoparticle interactions: opportunities and challenges","volume":"5","author":"Mahmoudi","year":"2013","journal-title":"Nanoscale"},{"key":"10.1016\/j.cis.2026.103965_bb0615","doi-asserted-by":"crossref","DOI":"10.1016\/j.cis.2025.103501","article-title":"Chiroptical hybrid nanomaterials based on metal nanoparticles and biomolecules","volume":"341","author":"N\u00fa\u00f1ez-Mart\u00ednez","year":"2025","journal-title":"Adv Colloid Interf Sci"},{"key":"10.1016\/j.cis.2026.103965_bb0620","first-page":"13","article-title":"Mechanistic understanding of the interactions between nano-objects with different surface properties and \u03b1-synuclein","author":"Mohammad-Beigi","year":"2019","journal-title":"ACS Nano"},{"key":"10.1016\/j.cis.2026.103965_bb0625","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1021\/acs.biochem.3c00624","article-title":"Alpha-synuclein aggregation mechanism in the presence of nanomaterials","volume":"63","author":"Malik","year":"2024","journal-title":"Biochemistry"},{"key":"10.1016\/j.cis.2026.103965_bb0630","doi-asserted-by":"crossref","DOI":"10.1016\/j.cis.2022.102824","article-title":"Detection and modulation of neurodegenerative processes using graphene-based nanomaterials: Nanoarchitectonics and applications","volume":"311","author":"Tiwari","year":"2023","journal-title":"Adv Colloid Interf Sci"},{"key":"10.1016\/j.cis.2026.103965_bb0635","first-page":"258","article-title":"Silica nanoparticles induce alpha-synuclein induction and aggregation in PC12-cells","author":"Xie","year":"2016","journal-title":"Chem Biol Interact"},{"key":"10.1016\/j.cis.2026.103965_bb0640","first-page":"39","article-title":"Naringenin-functionalized gold nanoparticles and their role in \u03b1-synuclein stabilization","author":"Maity","year":"2023","journal-title":"Langmuir"},{"key":"10.1016\/j.cis.2026.103965_bb0645","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijbiomac.2025.143144","article-title":"Zinc oxide nanoparticle interface moderation enhances the extent of \u03b1-synuclein sequestering against the protein amyloidosis","volume":"310","author":"Mohanty","year":"2025","journal-title":"Int J Biol Macromol"},{"key":"10.1016\/j.cis.2026.103965_bb0650","doi-asserted-by":"crossref","DOI":"10.1016\/j.cis.2022.102656","article-title":"Interactions of proteins with metal-based nanoparticles from a point of view of analytical chemistry - Challenges and opportunities","volume":"304","author":"Drozd","year":"2022","journal-title":"Adv Colloid Interf Sci"},{"key":"10.1016\/j.cis.2026.103965_bb0655","doi-asserted-by":"crossref","DOI":"10.1016\/j.cis.2022.102614","article-title":"Revealing local molecular distribution, orientation, phase separation, and formation of domains in artificial lipid layers: Towards comprehensive characterization of biological membranes","volume":"301","author":"Sofi\u0144ska","year":"2022","journal-title":"Adv Colloid Interf Sci"},{"key":"10.1016\/j.cis.2026.103965_bb0660","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1016\/j.jcis.2024.04.111","article-title":"In silico study on graphene quantum dots modified with various functional groups inhibiting \u03b1-synuclein dimerization","volume":"667","author":"Wu","year":"2024","journal-title":"J Colloid Interface Sci"},{"key":"10.1016\/j.cis.2026.103965_bb0665","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.cis.2013.10.015","article-title":"Probing the interplay between amyloidogenic proteins and membranes using lipid monolayers and bilayers","volume":"207","author":"Relini","year":"2014","journal-title":"Adv Colloid Interf Sci"},{"key":"10.1016\/j.cis.2026.103965_bb0670","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1021\/acschemneuro.3c00671","article-title":"Phospholipids and cholesterol determine molecular mechanisms of cytotoxicity of \u03b1-synuclein oligomers and fibrils","volume":"15","author":"Zhaliazka","year":"2024","journal-title":"ACS Chem Neurosci"},{"key":"10.1016\/j.cis.2026.103965_bb0675","first-page":"4","article-title":"Interplay of \u03b1-synuclein with lipid membranes: cooperative adsorption, membrane remodeling and coaggregation","author":"Makasewicz","year":"2024","journal-title":"JACS Au"},{"key":"10.1016\/j.cis.2026.103965_bb0680","doi-asserted-by":"crossref","first-page":"1582","DOI":"10.1021\/acs.jpcb.0c09192","article-title":"Membrane remodeling and stimulation of aggregation following \u03b1-synuclein adsorption to phosphotidylserine vesicles","volume":"125","author":"Hoover","year":"2021","journal-title":"J Phys Chem B"},{"key":"10.1016\/j.cis.2026.103965_bb0685","doi-asserted-by":"crossref","first-page":"2002","DOI":"10.1016\/j.bbamem.2015.06.021","article-title":"\u03b1-Synuclein interactions with phospholipid model membranes: Key roles for electrostatic interactions and lipid-bilayer structure","volume":"1848","author":"Pirc","year":"2015","journal-title":"Biochim Biophys Acta Biomembr"},{"key":"10.1016\/j.cis.2026.103965_bb0690","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1007\/s00401-023-02555-3","article-title":"Phosphatidylinositol-3,4,5-trisphosphate interacts with alpha-synuclein and initiates its aggregation and formation of Parkinson\u2019s disease-related fibril polymorphism","volume":"145","author":"Choong","year":"2023","journal-title":"Acta Neuropathol"},{"key":"10.1016\/j.cis.2026.103965_bb0695","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1016\/j.bbapap.2019.06.006","article-title":"Assembly of \u03b1-synuclein aggregates on phospholipid bilayers","volume":"1867","author":"Lv","year":"2019","journal-title":"Biochim Biophys Acta, Proteins Proteomics"},{"key":"10.1016\/j.cis.2026.103965_bb0700","doi-asserted-by":"crossref","first-page":"3788","DOI":"10.1016\/j.febslet.2008.10.009","article-title":"Membrane binding of oligomeric \u03b1-synuclein depends on bilayer charge and packing","volume":"582","author":"van Rooijen","year":"2008","journal-title":"FEBS Lett"},{"key":"10.1016\/j.cis.2026.103965_bb0705","first-page":"99","article-title":"Effects of curvature and composition on \u03b1-synuclein binding to lipid vesicles","author":"Middleton","year":"2010","journal-title":"Biophys J"},{"issue":"1","key":"10.1016\/j.cis.2026.103965_bb0710","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1038\/s41531-019-0103-7","article-title":"Parkinson\u2019s disease: proteinopathy or lipidopathy?","volume":"6","author":"Fanning","year":"2020","journal-title":"Npj Parkinson\u2019s Dis"},{"key":"10.1016\/j.cis.2026.103965_bb0715","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1038\/s41582-025-01142-2","article-title":"Parkinson disease is a fatty acidopathy","volume":"21","author":"Fanning","year":"2025","journal-title":"Nat Rev Neurol"},{"issue":"3","key":"10.1016\/j.cis.2026.103965_bb0720","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1007\/s00401-023-02601-0","article-title":"More than meets the eye in Parkinson\u2019s disease and other synucleinopathies: from proteinopathy to lipidopathy","volume":"146","author":"Flores-Leon","year":"2023","journal-title":"Acta Neuropathol"},{"issue":"2024","key":"10.1016\/j.cis.2026.103965_bb0725","first-page":"14","article-title":"Interaction between \u03b1-synuclein and bioactive lipids: neurodegeneration, disease biomarkers and emerging therapies","volume":"14","author":"Sanluca","year":"2024","journal-title":"Metabolites"},{"key":"10.1016\/j.cis.2026.103965_bb0730","first-page":"418","article-title":"Amyloid pores from pathogenic mutations","author":"Lashuel","year":"2002","journal-title":"Nature"},{"key":"10.1016\/j.cis.2026.103965_bb0735","doi-asserted-by":"crossref","first-page":"2838","DOI":"10.1111\/febs.12824","article-title":"\u03b1-Synuclein oligomers distinctively permeabilize complex model membranes","volume":"281","author":"Stefanovic","year":"2014","journal-title":"FEBS J"},{"key":"10.1016\/j.cis.2026.103965_bb0740","first-page":"2417","article-title":"4-Oxo-2-nonenal-induced \u03b1-synuclein oligomers interact with membranes in the cell","volume":"62","author":"Andersen","year":"2023","journal-title":"Lead Mitochond Fragment Biochem"},{"key":"10.1016\/j.cis.2026.103965_bb0745","first-page":"279","article-title":"Role of \u03b1-synuclein penetration into the membrane in the mechanisms of oligomer pore formation","author":"Tsigelny","year":"2012","journal-title":"FEBS J"},{"key":"10.1016\/j.cis.2026.103965_bb0750","first-page":"14","article-title":"Basic mechanisms of neurodegeneration: A critical update","author":"Jellinger","year":"2010","journal-title":"J Cell Mol Med"},{"key":"10.1016\/j.cis.2026.103965_bb0755","doi-asserted-by":"crossref","first-page":"3634","DOI":"10.1021\/acschemneuro.5c00356","article-title":"The aggregation continuum of \u03b1-synuclein and its relevance to brain aging","volume":"16","author":"Rana","year":"2025","journal-title":"ACS Chem Neurosci"},{"issue":"1","key":"10.1016\/j.cis.2026.103965_bb0760","doi-asserted-by":"crossref","first-page":"1814","DOI":"10.1038\/s41467-021-21937-3","article-title":"The release of toxic oligomers from \u03b1-synuclein fibrils induces dysfunction in neuronal cells","volume":"12","author":"Cascella","year":"2021","journal-title":"Nat Commun"},{"key":"10.1016\/j.cis.2026.103965_bb0765","first-page":"23","article-title":"\u03b1-synuclein toxicity in neurodegeneration: mechanism and therapeutic strategies","author":"Wong","year":"2017","journal-title":"Nat Med"},{"key":"10.1016\/j.cis.2026.103965_bb0770","first-page":"10","article-title":"Alpha-synuclein oligomers-neurotoxic molecules in Parkinson\u2019s disease and other lewy body disorders","author":"Ingelsson","year":"2016","journal-title":"Front Neurosci"},{"key":"10.1016\/j.cis.2026.103965_bb0775","first-page":"25","article-title":"The role of \u03b1-synuclein in etiology of neurodegenerative diseases","author":"Krawczuk","year":"2024","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.cis.2026.103965_bb0780","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1111\/jnc.14955","article-title":"A simple, versatile and robust centrifugation-based filtration protocol for the isolation and quantification of \u03b1-synuclein monomers, oligomers and fibrils: Towards improving experimental reproducibility in \u03b1-synuclein research","volume":"153","author":"Kumar","year":"2020","journal-title":"J Neurochem"},{"key":"10.1016\/j.cis.2026.103965_bb0785","first-page":"150","article-title":"Cellular models of alpha-synuclein toxicity and aggregation","author":"Delenclos","year":"2019","journal-title":"J Neurochem"},{"key":"10.1016\/j.cis.2026.103965_bb0790","first-page":"106","article-title":"Accumulation and clearance of \u03b1-synuclein aggregates demonstrated by time-lapse imaging","author":"Opazo","year":"2008","journal-title":"J Neurochem"},{"key":"10.1016\/j.cis.2026.103965_bb0795","first-page":"20","article-title":"Detection of novel intracellular O-synuclein oligomeric species by fluorescence lifetime imaging","author":"Klucken","year":"2006","journal-title":"FASEB J"},{"key":"10.1016\/j.cis.2026.103965_bb0800","first-page":"19","article-title":"Targeting \u03b1-synuclein oligomers by protein-fragment complementation for drug discovery in synucleinopathies","author":"Moussaud","year":"2015","journal-title":"Expert Opin Ther Targets"},{"key":"10.1016\/j.cis.2026.103965_bb0805","first-page":"138","article-title":"Direct visualization of alpha-synuclein oligomers reveals previously undetected pathology in Parkinson\u2019s disease brain","author":"Roberts","year":"2015","journal-title":"Brain"},{"key":"10.1016\/j.cis.2026.103965_bb0810","first-page":"24","article-title":"Saccharomyces cerevisiae as a model for studying human neurodegenerative disorders: viral capsid protein expression","author":"Bayandina","year":"2023","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.cis.2026.103965_bb0815","first-page":"72","article-title":"Modeling the cellular fate of alpha-synuclein aggregates: A pathway to pathology","author":"Marotta","year":"2022","journal-title":"Curr Opin Neurobiol"},{"key":"10.1016\/j.cis.2026.103965_bb0820","first-page":"3","article-title":"Formation of toxic oligomeric \u03b1-synuclein species in living cells","author":"Outeiro","year":"2008","journal-title":"PLoS One"},{"key":"10.1016\/j.cis.2026.103965_bb0825","doi-asserted-by":"crossref","DOI":"10.3791\/51751-v","article-title":"Primary culture of mouse dopaminergic neurons","author":"Gaven","year":"2014","journal-title":"J Vis Exp"},{"key":"10.1016\/j.cis.2026.103965_bb0830","article-title":"Alpha-synuclein mutations impair axonal regeneration in models of Parkinson\u2019s disease","volume":"6","author":"Tonges","year":"2014","journal-title":"Front Aging Neurosci"},{"key":"10.1016\/j.cis.2026.103965_bb0835","first-page":"21","article-title":"Expression of A53T mutant but not wild-type \u03b1-synuclein in PC12 cells induces alterations of the ubiquitin-dependent degradation system, loss of dopamine release, and autophagic cell death","author":"Stefanis","year":"2001","journal-title":"J Neurosci"},{"key":"10.1016\/j.cis.2026.103965_bb0840","first-page":"12","article-title":"The SH-SY5Y cell line in Parkinson\u2019s disease research: a systematic review","author":"Xicoy","year":"2017","journal-title":"Mol Neurodegener"},{"key":"10.1016\/j.cis.2026.103965_bb0845","first-page":"26","article-title":"\u03b1-Synuclein overexpression in PC12 and chromaffin cells impairs catecholamine release by interfering with a late step in exocytosis","author":"Larsen","year":"2006","journal-title":"J Neurosci"},{"key":"10.1016\/j.cis.2026.103965_bb0850","first-page":"5","article-title":"Toxic oligomeric alpha-synuclein variants present in human Parkinson\u2019s disease brains are differentially generated in mammalian cell models","author":"Xin","year":"2015","journal-title":"Biomolecules"},{"key":"10.1016\/j.cis.2026.103965_bb0855","first-page":"106","article-title":"Inclusion formation and neuronal cell death through neuron-to-neuron transmission of \u03b1-synuclein","author":"Desplats","year":"2009","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.cis.2026.103965_bb0860","first-page":"12","article-title":"Advancing stem cell models of alpha-synuclein gene regulation in neurodegenerative disease","author":"Piper","year":"2018","journal-title":"Front Neurosci"},{"key":"10.1016\/j.cis.2026.103965_bb0865","first-page":"46","article-title":"Primary skin fibroblasts as a model of Parkinson\u2019s disease","author":"Auburger","year":"2012","journal-title":"Mol Neurobiol"},{"key":"10.1016\/j.cis.2026.103965_bb0870","first-page":"8","article-title":"Directly converted iNeuron as a screening model for pathogenic variants","author":"Lim","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.cis.2026.103965_bb0875","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.cell.2012.11.045","article-title":"Direct conversion of fibroblasts to neurons by reprogramming PTB-regulated MicroRNA circuits","volume":"152","author":"Xue","year":"2013","journal-title":"Cell"},{"key":"10.1016\/j.cis.2026.103965_bb0880","first-page":"23","article-title":"Roles of \u03b1-synuclein and disease-associated factors in drosophila models of Parkinson\u2019s disease","author":"Suzuki","year":"2022","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.cis.2026.103965_bb0885","first-page":"10","article-title":"Invertebrate models untangle the mechanism of neurodegeneration in Parkinson\u2019s disease","author":"Surguchov","year":"2021","journal-title":"Cells"},{"key":"10.1016\/j.cis.2026.103965_bb0890","first-page":"11","article-title":"Modeling neurodegeneration in zebrafish","author":"Xi","year":"2011","journal-title":"Curr Neurol Neurosci Rep"},{"key":"10.1016\/j.cis.2026.103965_bb0895","first-page":"13","article-title":"A new zebrafish model to measure neuronal \u03b1-synuclein clearance in vivo","author":"Lopez","year":"2022","journal-title":"Genes (Basel)"},{"key":"10.1016\/j.cis.2026.103965_bb0900","first-page":"9","article-title":"Addition of exogenous \u03b1-synuclein preformed fibrils to primary neuronal cultures to seed recruitment of endogenous \u03b1-synuclein to Lewy body and Lewy neurite-like aggregates","author":"Volpicelli-Daley","year":"2014","journal-title":"Nat Protoc"},{"key":"10.1016\/j.cis.2026.103965_bb0905","first-page":"7","article-title":"The role of alpha-synuclein oligomerization and aggregation in cellular and animal models of Parkinson\u2019s disease","author":"Wan","year":"2012","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.cis.2026.103965_bb0910","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1038\/s41531-025-01075-z","article-title":"Oligomeric alpha-synuclein causes early synaptic dysfunction of the corticostriatal pathway associated with non-motor symptoms","volume":"11","author":"Bellingacci","year":"2025","journal-title":"Npj Parkinson\u2019s Dis"},{"key":"10.1016\/j.cis.2026.103965_bb0915","doi-asserted-by":"crossref","first-page":"1496","DOI":"10.1093\/brain\/awu057","article-title":"Accumulation of oligomer-prone \u03b1-synuclein exacerbates synaptic and neuronal degeneration in vivo","volume":"137","author":"Rockenstein","year":"2014","journal-title":"Brain"},{"key":"10.1016\/j.cis.2026.103965_bb0920","doi-asserted-by":"crossref","DOI":"10.3389\/fnins.2021.643391","article-title":"Low-expressing synucleinopathy mouse models based on oligomer-forming mutations and C-terminal truncation of \u03b1-synuclein","volume":"15","author":"Martinez Hernandez","year":"2021","journal-title":"Front Neurosci"},{"key":"10.1016\/j.cis.2026.103965_bb0925","doi-asserted-by":"crossref","first-page":"3409","DOI":"10.1523\/JNEUROSCI.4977-09.2010","article-title":"Distinct region-specific \u03b1-synuclein oligomers in A53T transgenic mice: implications for neurodegeneration","volume":"30","author":"Tsika","year":"2010","journal-title":"J Neurosci"},{"key":"10.1016\/j.cis.2026.103965_bb0930","doi-asserted-by":"crossref","first-page":"4194","DOI":"10.1073\/pnas.1100976108","article-title":"In vivo demonstration that \u03b1-synuclein oligomers are toxic","volume":"108","author":"Winner","year":"2011","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.cis.2026.103965_bb0935","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.ebiom.2018.01.035","article-title":"Bimolecular fluorescence complementation of alpha-synuclein demonstrates its oligomerization with dopaminergic phenotype in mice","volume":"29","author":"Cai","year":"2018","journal-title":"EBioMedicine"},{"key":"10.1016\/j.cis.2026.103965_bb0940","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1111\/jnc.15147","article-title":"Monitoring alpha-synuclein oligomerization and aggregation using bimolecular fluorescence complementation assays: what you see is not always what you get","volume":"157","author":"Frey","year":"2021","journal-title":"J Neurochem"},{"key":"10.1016\/j.cis.2026.103965_bb0945","article-title":"The endothelial surface layer-glycocalyx - Universal nano-infrastructure is fundamental to physiology, cell traffic and a complementary neural network","volume":"338","author":"Reines","year":"2025","journal-title":"Adv Colloid Interf Sci"},{"key":"10.1016\/j.cis.2026.103965_bb0950","first-page":"12","article-title":"Modeling alpha-synuclein pathology in a human brain-chip to assess blood-brain barrier disruption","author":"Pediaditakis","year":"2021","journal-title":"Nat Commun"},{"key":"10.1016\/j.cis.2026.103965_bb0955","first-page":"72","article-title":"Neuron-to-neuron transmission of \u03b1-synuclein fibrils through axonal transport","author":"Freundt","year":"2012","journal-title":"Ann Neurol"},{"key":"10.1016\/j.cis.2026.103965_bb0960","first-page":"24","article-title":"Human iPSC-derived blood-brain barrier chips enable disease modeling and personalized medicine applications","author":"Vatine","year":"2019","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.cis.2026.103965_bb0965","first-page":"15","article-title":"Differentiation of neuroepithelial stem cells into functional dopaminergic neurons in 3D microfluidic cell culture","author":"Moreno","year":"2015","journal-title":"Lab Chip"},{"key":"10.1016\/j.cis.2026.103965_bb0970","first-page":"11","article-title":"Reproducing human and cross-species drug toxicities using a Liver-Chip","author":"Jang","year":"2019","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.cis.2026.103965_bb0975","article-title":"\u03b1-Synuclein driven cell susceptibility in Parkinson\u2019s disease","author":"Breiter","year":"2025","journal-title":"BioRxiv"},{"issue":"11","key":"10.1016\/j.cis.2026.103965_bb0980","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1038\/s41419-019-2091-2","article-title":"Mitochondrial damage by \u03b1-synuclein causes cell death in human dopaminergic neurons","volume":"10","author":"Ganjam","year":"2019","journal-title":"Cell Death Dis"},{"key":"10.1016\/j.cis.2026.103965_bb0985","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1111\/j.1460-9568.2010.07266.x","article-title":"\u03b1-Synuclein mediates alterations in membrane conductance: a potential role for \u03b1-synuclein oligomers in cell vulnerability","volume":"32","author":"Feng","year":"2010","journal-title":"Eur J Neurosci"},{"key":"10.1016\/j.cis.2026.103965_bb0990","first-page":"135","article-title":"Membrane remodeling by \u03b1-synuclein and effects on amyloid formation","author":"Jiang","year":"2013","journal-title":"J Am Chem Soc"},{"key":"10.1016\/j.cis.2026.103965_bb0995","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/j.jmb.2009.03.021","article-title":"The first N-terminal amino acids of \u03b1-synuclein are essential for \u03b1-helical structure formation in vitro and membrane binding in yeast","volume":"389","author":"Vamvaca","year":"2009","journal-title":"J Mol Biol"},{"key":"10.1016\/j.cis.2026.103965_bb1000","first-page":"3","article-title":"Alpha-synuclein aggregates trigger cardiolipin externalization and mitophagy","author":"Mart\u00edn-Jim\u00e9nez","year":"2024","journal-title":"Autoph Reports"},{"key":"10.1016\/j.cis.2026.103965_bb1005","first-page":"9","article-title":"Cardiolipin exposure on the outer mitochondrial membrane modulates \u03b1-synuclein","author":"Ryan","year":"2018","journal-title":"Nat Commun"},{"key":"10.1016\/j.cis.2026.103965_bb1010","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1038\/s41531-023-00583-0","article-title":"Extracellular high molecular weight \u03b1-synuclein oligomers induce cell death by disrupting the plasma membrane","volume":"9","author":"Ito","year":"2023","journal-title":"NPJ Parkinsons Dis"},{"issue":"11","key":"10.1016\/j.cis.2026.103965_bb1015","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1038\/s41419-023-06251-8","article-title":"Aggregation of alpha-synuclein disrupts mitochondrial metabolism and induce mitophagy via cardiolipin externalization","volume":"14","author":"Lurette","year":"2023","journal-title":"Cell Death Dis"},{"key":"10.1016\/j.cis.2026.103965_bb1020","doi-asserted-by":"crossref","DOI":"10.1016\/j.brainres.2024.148920","article-title":"Targeting VDAC: A potential therapeutic approach for mitochondrial dysfunction in Alzheimer\u2019s disease","volume":"1835","author":"Yang","year":"2024","journal-title":"Brain Res"},{"key":"10.1016\/j.cis.2026.103965_bb1025","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.abb.2018.04.018","article-title":"Alpha-synuclein mitochondrial interaction leads to irreversible translocation and complex I impairment","volume":"651","author":"Mart\u00ednez","year":"2018","journal-title":"Arch Biochem Biophys"},{"key":"10.1016\/j.cis.2026.103965_bb1030","doi-asserted-by":"crossref","first-page":"9089","DOI":"10.1074\/jbc.M710012200","article-title":"Mitochondrial import and accumulation of \u03b1-synuclein impair complex I in human dopaminergic neuronal cultures and Parkinson disease brain","volume":"283","author":"Devi","year":"2008","journal-title":"J Biol Chem"},{"key":"10.1016\/j.cis.2026.103965_bb1035","doi-asserted-by":"crossref","DOI":"10.1016\/j.cis.2026.103880","article-title":"Gut, brain and the Glycocalyx: A portrait of Parkinsons disease","volume":"353","author":"Ninham","year":"2026","journal-title":"Adv Colloid Interf Sci"},{"key":"10.1016\/j.cis.2026.103965_bb1040","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1016\/j.tcb.2018.03.004","article-title":"Ca 2+ -triggered synaptic vesicle fusion initiated by release of inhibition","volume":"28","author":"Brunger","year":"2018","journal-title":"Trends Cell Biol"},{"key":"10.1016\/j.cis.2026.103965_bb1045","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.conb.2018.03.005","article-title":"Presynaptic origins of distinct modes of neurotransmitter release","volume":"51","author":"Chanaday","year":"2018","journal-title":"Curr Opin Neurobiol"},{"key":"10.1016\/j.cis.2026.103965_bb1050","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1111\/jnc.15181","article-title":"Disorders of synaptic vesicle fusion machinery","volume":"157","author":"Melland","year":"2021","journal-title":"J Neurochem"},{"key":"10.1016\/j.cis.2026.103965_bb1055","doi-asserted-by":"crossref","first-page":"5221","DOI":"10.1523\/JNEUROSCI.4650-14.2015","article-title":"Definition of a molecular pathway mediating \u03b1-synuclein neurotoxicity","volume":"35","author":"Burr\u00e9","year":"2015","journal-title":"J Neurosci"},{"key":"10.1016\/j.cis.2026.103965_bb1060","doi-asserted-by":"crossref","first-page":"4087","DOI":"10.1073\/pnas.1218424110","article-title":"Large \u03b1-synuclein oligomers inhibit neuronal SNARE-mediated vesicle docking","volume":"110","author":"Choi","year":"2013","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.cis.2026.103965_bb1065","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-021-90503-0","article-title":"Cooperative inhibition of SNARE-mediated vesicle fusion by \u03b1-synuclein monomers and oligomers","volume":"11","author":"Yoo","year":"2021","journal-title":"Sci Rep"},{"key":"10.1016\/j.cis.2026.103965_bb1070","doi-asserted-by":"crossref","first-page":"6207","DOI":"10.1113\/JP286281","article-title":"Acute introduction of monomeric or multimeric \u03b1-synuclein induces distinct impacts on synaptic vesicle trafficking at lamprey giant synapses","volume":"603","author":"Rom\u00e1n-Vendrell","year":"2025","journal-title":"J Physiol"},{"key":"10.1016\/j.cis.2026.103965_bb1075","doi-asserted-by":"crossref","first-page":"6137521","DOI":"10.1155\/2020\/6137521","article-title":"Oxidative stress and neuroinflammation potentiate each other to promote progression of dopamine neurodegeneration","volume":"2020","author":"He","year":"2020","journal-title":"Oxidative Med Cell Longev"},{"key":"10.1016\/j.cis.2026.103965_bb1080","doi-asserted-by":"crossref","first-page":"205","DOI":"10.3233\/JPD-2011-11040","article-title":"Generation of ferric iron links oxidative stress to \u03b1-synuclein oligomer formation","volume":"1","author":"Levin","year":"2011","journal-title":"J Parkinsons Dis"},{"key":"10.1016\/j.cis.2026.103965_bb1085","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1007\/s00702-020-02192-0","article-title":"The role of alpha-synuclein as ferrireductase in neurodegeneration associated with Parkinson\u2019s disease","volume":"127","author":"Sian-Hulsmann","year":"2020","journal-title":"J Neural Transm"},{"key":"10.1016\/j.cis.2026.103965_bb1090","doi-asserted-by":"crossref","DOI":"10.1155\/2014\/428764","article-title":"S-nitrosation and ubiquitin-proteasome system interplay in neuromuscular disorders","volume":"2014","author":"Rizza","year":"2014","journal-title":"Int J Cell Biol"},{"key":"10.1016\/j.cis.2026.103965_bb1095","first-page":"357","article-title":"Dopamine oxidation mediates mitochondrial and lysosomal dysfunction in Parkinson\u2019s disease","volume":"2017","author":"Burbulla","year":"1979","journal-title":"Science"},{"key":"10.1016\/j.cis.2026.103965_bb1100","first-page":"241","article-title":"Periodic entanglement I: networks from hyperbolic reticulations","volume":"69","author":"Evans","year":"2013","journal-title":"Urn"},{"issue":"2018","key":"10.1016\/j.cis.2026.103965_bb1105","first-page":"19","article-title":"What is the evidence that Parkinson\u2019s disease is a prion disorder, which originates in the gut?","volume":"19","author":"Kujawska","year":"2018","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.cis.2026.103965_bb1110","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1186\/s40478-018-0532-2","article-title":"Potent prion-like behaviors of pathogenic \u03b1-synuclein and evaluation of inactivation methods","volume":"6","author":"Tarutani","year":"2018","journal-title":"Acta Neuropathol Commun"},{"key":"10.1016\/j.cis.2026.103965_bb1115","first-page":"10","article-title":"Tunneling nanotubes and gap junctions-their role in long-range intercellular communication during development, health, and disease conditions","author":"Ariazi","year":"2017","journal-title":"Front Mol Neurosci"},{"key":"10.1016\/j.cis.2026.103965_bb1120","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/j.mod.2012.11.006","article-title":"Tunneling nanotubes, an emerging intercellular communication route in development","volume":"130","author":"Gerdes","year":"2013","journal-title":"Mech Dev"},{"key":"10.1016\/j.cis.2026.103965_bb1125","doi-asserted-by":"crossref","first-page":"2120","DOI":"10.15252\/embj.201593411","article-title":"Tunneling nanotubes spread fibrillar \u03b1-synuclein by intercellular trafficking of lysosomes","volume":"35","author":"Abounit","year":"2016","journal-title":"EMBO J"},{"key":"10.1016\/j.cis.2026.103965_bb1130","doi-asserted-by":"crossref","first-page":"2633","DOI":"10.1083\/jcb.201701047","article-title":"The spread of prion-like proteins by lysosomes and tunneling nanotubes: Implications for neurodegenerative diseases","volume":"216","author":"Victoria","year":"2017","journal-title":"J Cell Biol"},{"key":"10.1016\/j.cis.2026.103965_bb1135","doi-asserted-by":"crossref","DOI":"10.1016\/j.jmb.2022.167930","article-title":"The hidden cell-to-cell trail of \u03b1-synuclein aggregates","volume":"435","author":"Neupane","year":"2023","journal-title":"J Mol Biol"},{"key":"10.1016\/j.cis.2026.103965_bb1140","doi-asserted-by":"crossref","DOI":"10.1016\/j.aca.2024.342559","article-title":"An \u03b1-helical peptide-based plasmonic biosensor for highly specific detection of \u03b1-synuclein toxic oligomers","volume":"1304","author":"Giarola","year":"2024","journal-title":"Anal Chim Acta"},{"key":"10.1016\/j.cis.2026.103965_bb1145","first-page":"145","article-title":"Electrochemiluminescent aptamer-sensor for alpha synuclein oligomer based on a metal-organic framework","author":"Wu","year":"2020","journal-title":"Analyst"},{"issue":"12","key":"10.1016\/j.cis.2026.103965_bb1150","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1038\/s41578-020-0229-6","article-title":"Solid-state nanopore sensors","volume":"5","author":"Xue","year":"2020","journal-title":"Nat Rev Mater"},{"key":"10.1016\/j.cis.2026.103965_bb1155","doi-asserted-by":"crossref","first-page":"4653","DOI":"10.1021\/acs.jpclett.2c00960","article-title":"Dynamic chemistry interactions: controlled single-entity electrochemistry","volume":"13","author":"Lu","year":"2022","journal-title":"J Phys Chem Lett"},{"key":"10.1016\/j.cis.2026.103965_bb1160","doi-asserted-by":"crossref","first-page":"15720","DOI":"10.1021\/jacs.8b11970","article-title":"Nanopore-Based Single-Biomolecule Interfaces: From Information to Knowledge","volume":"141","author":"Ying","year":"2019","journal-title":"J Am Chem Soc"},{"key":"10.1016\/j.cis.2026.103965_bb1165","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1093\/brain\/awab306","article-title":"Imaging protein aggregates in the serum and cerebrospinal fluid in Parkinson\u2019s disease","volume":"145","author":"Lobanova","year":"2022","journal-title":"Brain"},{"issue":"1","key":"10.1016\/j.cis.2026.103965_bb1170","doi-asserted-by":"crossref","first-page":"5512","DOI":"10.1038\/s41467-022-33252-6","article-title":"Small soluble \u03b1-synuclein aggregates are the toxic species in Parkinson\u2019s disease","volume":"13","author":"Emin","year":"2022","journal-title":"Nat Commun"},{"key":"10.1016\/j.cis.2026.103965_bb1175","first-page":"2","article-title":"A same day \u03b1-synuclein RT-QuIC seed amplification assay for synucleinopathy biospecimens","author":"Parveen","year":"2025","journal-title":"Npj Biosens"},{"key":"10.1016\/j.cis.2026.103965_bb1180","doi-asserted-by":"crossref","DOI":"10.3389\/fnagi.2022.853050","article-title":"Real-time quaking- induced conversion assays for prion diseases, synucleinopathies, and tauopathies","volume":"14","author":"Vascellari","year":"2022","journal-title":"Front Aging Neurosci"},{"key":"10.1016\/j.cis.2026.103965_bb1185","first-page":"578","article-title":"Discriminating \u03b1-synuclein strains in Parkinson\u2019s disease and multiple system atrophy","author":"Shahnawaz","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.cis.2026.103965_bb1190","first-page":"8","article-title":"Efficient RT-QuIC seeding activity for \u03b1-synuclein in olfactory mucosa samples of patients with Parkinson\u2019s disease and multiple system atrophy","author":"De Luca","year":"2019","journal-title":"Transl Neurodegener"},{"key":"10.1016\/j.cis.2026.103965_bb1195","first-page":"35","article-title":"Blinded RT-QuIC analysis of \u03b1-synuclein biomarker in skin tissue from Parkinson\u2019s disease patients","author":"Manne","year":"2020","journal-title":"Mov Disord"},{"key":"10.1016\/j.cis.2026.103965_bb1200","first-page":"78","article-title":"Skin \u03b1-synuclein aggregation seeding activity as a novel biomarker for Parkinson disease","author":"Wang","year":"2021","journal-title":"JAMA Neurol"},{"key":"10.1016\/j.cis.2026.103965_bb1205","first-page":"18","article-title":"Seed amplification assay for the detection of pathologic alpha-synuclein aggregates in cerebrospinal fluid","author":"Concha-Marambio","year":"2023","journal-title":"Nat Protoc"},{"key":"10.1016\/j.cis.2026.103965_bb1210","first-page":"6","article-title":"Rapid and ultra-sensitive quantitation of disease-associated \u03b1-synuclein seeds in brain and cerebrospinal fluid by \u03b1Syn RT-QuIC","author":"Groveman","year":"2018","journal-title":"Acta Neuropathol Commun"},{"key":"10.1016\/j.cis.2026.103965_bb1215","first-page":"14","article-title":"Ultrasensitive detection of aggregated \u03b1-synuclein in glial cells, human cerebrospinal fluid, and brain tissue using the RT-QuIC assay: new high-throughput neuroimmune biomarker assay for Parkinsonian disorders","author":"Manne","year":"2019","journal-title":"J NeuroImmune Pharmacol"},{"key":"10.1016\/j.cis.2026.103965_bb1220","first-page":"8","article-title":"A rapid \u03b1-synuclein seed assay of Parkinson\u2019s disease CSF panel shows high diagnostic accuracy","author":"Orr\u00f9","year":"2021","journal-title":"Ann Clin Transl Neurol"},{"key":"10.1016\/j.cis.2026.103965_bb1225","first-page":"9","article-title":"High diagnostic performance of independent alpha-synuclein seed amplification assays for detection of early Parkinson\u2019s disease","author":"Russo","year":"2021","journal-title":"Acta Neuropathol Commun"},{"key":"10.1016\/j.cis.2026.103965_bb1230","first-page":"140","article-title":"Ultrasensitive RT-QuIC assay with high sensitivity and specificity for Lewy body-associated synucleinopathies","author":"Rossi","year":"2020","journal-title":"Acta Neuropathol"},{"key":"10.1016\/j.cis.2026.103965_bb1235","first-page":"74","article-title":"Development of a biochemical diagnosis of Parkinson disease by detection of \u03b1-synuclein misfolded aggregates in cerebrospinal fluid","author":"Shahnawaz","year":"2017","journal-title":"JAMA Neurol"},{"key":"10.1016\/j.cis.2026.103965_bb1240","first-page":"14","article-title":"Diagnosing multiple system atrophy: current clinical guidance and emerging molecular biomarkers","author":"Goolla","year":"2023","journal-title":"Front Neurol"},{"key":"10.1016\/j.cis.2026.103965_bb1245","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1016\/S1474-4422(25)00157-7","article-title":"Diagnostic and prognostic value of \u03b1-synuclein seed amplification assay kinetic measures in Parkinson\u2019s disease: a longitudinal cohort study","volume":"24","author":"Orr\u00fa","year":"2025","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.cis.2026.103965_bb1250","first-page":"30","article-title":"Native top-down mass spectrometry and ion mobility spectrometry of the interaction of Tau protein with a molecular tweezer assembly modulator","author":"Nshanian","year":"2019","journal-title":"J Am Soc Mass Spectrom"},{"issue":"1","key":"10.1016\/j.cis.2026.103965_bb1255","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1038\/s42003-021-02126-w","article-title":"Super-resolution imaging reveals \u03b1-synuclein seeded aggregation in SH-SY5Y cells","volume":"4","author":"Sang","year":"2021","journal-title":"Commun Biol"},{"key":"10.1016\/j.cis.2026.103965_bb1260","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmc.2024.117613","article-title":"Discovery of small molecule benzothiazole and indole derivatives tackling tau 2N4R and \u03b1-synuclein fibrils","volume":"100","author":"Elbatrawy","year":"2024","journal-title":"Bioorg Med Chem"},{"key":"10.1016\/j.cis.2026.103965_bb1265","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1021\/acsomega.3c07453","article-title":"1,4-Diurea- and 1,4-Dithiourea-Substituted aromatic derivatives selectively inhibit \u03b1-synuclein oligomer formation in vitro","volume":"9","author":"Ganegamage","year":"2023","journal-title":"ACS Omega"},{"key":"10.1016\/j.cis.2026.103965_bb1270","doi-asserted-by":"crossref","first-page":"10392","DOI":"10.1074\/jbc.RA119.007743","article-title":"Defining \u03b1-synuclein species responsible for Parkinson\u2019s disease phenotypes in mice","volume":"294","author":"Froula","year":"2019","journal-title":"J Biol Chem"},{"key":"10.1016\/j.cis.2026.103965_bb1275","doi-asserted-by":"crossref","first-page":"33691","DOI":"10.1074\/jbc.M112.379792","article-title":"Novel one-step immunoassays to quantify \u03b1-Synuclein: applications for biomarker development and high-throughput screening","volume":"287","author":"Bidinosti","year":"2012","journal-title":"J Biol Chem"},{"key":"10.1016\/j.cis.2026.103965_bb1280","article-title":"Super-resolution microscopy of nanoscopic alpha-synuclein aggregates in brain samples indicates a subset of cells have disrupted protein homeostasis prior to Lewy body formation in Parkinson\u2019s disease","author":"Fertan","year":"2025","journal-title":"BioRxiv"},{"key":"10.1016\/j.cis.2026.103965_bb1285","first-page":"1","article-title":"Large-scale visualization of \u03b1-synuclein oligomers in Parkinson\u2019s disease brain tissue","volume":"2025","author":"Andrews","year":"2025","journal-title":"Nat Biomed Eng"},{"key":"10.1016\/j.cis.2026.103965_bb1290","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/2051-5960-1-6","article-title":"Direct detection of alpha synuclein oligomers in vivo","volume":"1","author":"Dimant","year":"2013","journal-title":"Acta Neuropathol Commun"},{"key":"10.1016\/j.cis.2026.103965_bb1295","first-page":"14","article-title":"Stabilization of \u03b1-synuclein oligomers using formaldehyde","author":"Ruesink","year":"2019","journal-title":"PLoS One"},{"key":"10.1016\/j.cis.2026.103965_bb1300","first-page":"23","article-title":"Structural and biophysical characterization of stable alpha-synuclein oligomers","author":"Vaikath","year":"2022","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.cis.2026.103965_bb1305","first-page":"594","article-title":"Intracellular soluble \u03b1-synuclein oligomers reduce pyramidal cell excitability","author":"Kaufmann","year":"2016","journal-title":"J Physiol"},{"key":"10.1016\/j.cis.2026.103965_bb1310","first-page":"157","article-title":"Alpha-synuclein oligomerization and aggregation: a model will always be a model","author":"Outeiro","year":"2021","journal-title":"J Neurochem"},{"key":"10.1016\/j.cis.2026.103965_bb1315","first-page":"139","article-title":"Structure, function and toxicity of alpha-synuclein: the Bermuda triangle in synucleinopathies","author":"Villar-Piqu\u00e9","year":"2016","journal-title":"J Neurochem"},{"key":"10.1016\/j.cis.2026.103965_bb1320","first-page":"12","article-title":"Production of recombinant alpha-synuclein: still no standardized protocol in sight","author":"Al-Azzani","year":"2022","journal-title":"Biomolecules"},{"key":"10.1016\/j.cis.2026.103965_bb1325","first-page":"13","article-title":"Alpha-synuclein as a biomarker of Parkinson\u2019s disease: good, but not good enough","author":"Ganguly","year":"2021","journal-title":"Front Aging Neurosci"},{"key":"10.1016\/j.cis.2026.103965_bb1330","first-page":"149","article-title":"A quantitative Lewy-fold-specific alpha-synuclein seed amplification assay as a progression marker for Parkinson\u2019s disease","author":"Bernhardt","year":"2025","journal-title":"Acta Neuropathol"},{"key":"10.1016\/j.cis.2026.103965_bb1335","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a041944","article-title":"\u03b1-Synuclein biomarkers for Parkinson\u2019s disease","author":"Lodge","year":"2025","journal-title":"Cold Spring Harb Perspect Med"},{"key":"10.1016\/j.cis.2026.103965_bb1340","doi-asserted-by":"crossref","DOI":"10.1002\/smll.201802412","article-title":"Nanopore-based, rapid characterization of individual amyloid particles in solution: concepts, challenges, and prospects","volume":"14","author":"Houghtaling","year":"2018","journal-title":"Small"},{"key":"10.1016\/j.cis.2026.103965_bb1345","doi-asserted-by":"crossref","DOI":"10.1016\/j.trac.2026.118837","article-title":"The evolutionary strategies for enhanced nanopore sensing","volume":"201","author":"Liu","year":"2026","journal-title":"TrAC Trends Anal Chem"},{"key":"10.1016\/j.cis.2026.103965_bb1350","first-page":"18","article-title":"QuipuNet: convolutional neural network for single-molecule nanopore sensing","author":"Misiunas","year":"2018","journal-title":"Nano Lett"},{"key":"10.1016\/j.cis.2026.103965_bb1355","first-page":"22","article-title":"SquiggleNet: real-time, direct classification of nanopore signals","author":"Bao","year":"2021","journal-title":"Genome Biol"},{"key":"10.1016\/j.cis.2026.103965_bb1360","doi-asserted-by":"crossref","DOI":"10.1016\/j.bios.2024.116632","article-title":"Integrating machine learning and biosensors in microfluidic devices: A review","volume":"263","author":"Antonelli","year":"2024","journal-title":"Biosens Bioelectron"},{"key":"10.1016\/j.cis.2026.103965_bb1365","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1016\/j.colsurfb.2017.07.090","article-title":"Two sides of the coin. Part 2. Colloid and surface science meets real biointerfaces","volume":"159","author":"Ninham","year":"2017","journal-title":"Colloids Surf B: Biointerfaces"},{"key":"10.1016\/j.cis.2026.103965_bb1370","doi-asserted-by":"crossref","first-page":"45","DOI":"10.36253\/Substantia-1751","article-title":"Boxing Partula: 25 Years after","volume":"7","author":"Hyde","year":"2023","journal-title":"Substantia"},{"key":"10.1016\/j.cis.2026.103965_bb1375","doi-asserted-by":"crossref","DOI":"10.1016\/j.cis.2025.103401","article-title":"The endothelial surface layer-glycocalyx - Universal nano-infrastructure is fundamental to physiology, cell traffic and a complementary neural network","volume":"338","author":"Ninham","year":"2025","journal-title":"Adv Colloid Interf Sci"},{"key":"10.1016\/j.cis.2026.103965_bb1380","doi-asserted-by":"crossref","first-page":"2286","DOI":"10.1021\/cr200271j","article-title":"Hofmeister phenomena: An update on ion specificity in biology","volume":"112","author":"Lo Nostro","year":"2012","journal-title":"Chem Rev"},{"key":"10.1016\/j.cis.2026.103965_bb1385","doi-asserted-by":"crossref","first-page":"7872","DOI":"10.1021\/acs.jpcb.0c05001","article-title":"Unexpected properties of degassed solutions","volume":"124","author":"Ninham","year":"2020","journal-title":"J Phys Chem B"},{"key":"10.1016\/j.cis.2026.103965_bb1390","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1016\/j.colsurfb.2017.01.022","article-title":"Two sides of the coin. Part 1. Lipid and surfactant self-assembly revisited","volume":"152","author":"Ninham","year":"2017","journal-title":"Colloids Surf B: Biointerfaces"},{"key":"10.1016\/j.cis.2026.103965_bb1395","doi-asserted-by":"crossref","first-page":"2866","DOI":"10.1021\/ja412105t","article-title":"The presence of an air-water interface affects formation and elongation of \u03b1-Synuclein fibrils","volume":"136","author":"Campioni","year":"2014","journal-title":"J Am Chem Soc"},{"key":"10.1016\/j.cis.2026.103965_bb1400","first-page":"4","article-title":"Advances in graphene-based nanoplatforms and their application in Parkinson\u2019s disease","author":"Oz","year":"2023","journal-title":"Mater Adv"},{"key":"10.1016\/j.cis.2026.103965_bb1405","first-page":"13","article-title":"Graphene quantum dots prevent \u03b1-synucleinopathy in Parkinson\u2019s disease","author":"Kim","year":"2018","journal-title":"Nat Nanotechnol"},{"key":"10.1016\/j.cis.2026.103965_bb1410","doi-asserted-by":"crossref","DOI":"10.1080\/14686996.2026.2662693","article-title":"Characterization and evaluation of the ability of graphene quantum dots to affect \u03b1-synuclein aggregation in synucleinopathy models","author":"Oz","year":"2026","journal-title":"Sci Technol Adv Mater"}],"container-title":["Advances in Colloid and Interface Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0001868626001909?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0001868626001909?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,11]],"date-time":"2026-08-11T00:38:55Z","timestamp":1786408735000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0001868626001909"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":282,"alternative-id":["S0001868626001909"],"URL":"https:\/\/doi.org\/10.1016\/j.cis.2026.103965","relation":{},"ISSN":["0001-8686"],"issn-type":[{"value":"0001-8686","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Nanoscale interrogation of \u03b1-Synuclein oligomers: Bridging biophysics, interface science, and neurobiology","name":"articletitle","label":"Article Title"},{"value":"Advances in Colloid and Interface Science","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cis.2026.103965","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"103965"}}